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Abstract
This study was aimed to characterize the distribution of colorectal cancer risk using family history 
of cancers by data mining. Family histories for 10,066 colorectal cancer cases recruited to 
population cancer registries of the Colon Cancer Family Registry were analyzed using a data 
mining framework. A novel index was developed to quantify familial cancer aggregation. 
Artificial neural network was used to identify distinct categories of familial risk. Standardized 
incidence ratios (SIRs) and corresponding 95% confidence intervals (CIs) of colorectal cancer 
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were calculated for each category. We identified five major, and sixty-six minor categories of 
familial risk for developing colorectal cancer. The distribution the major risk categories were: (i) 
7% of families (SIR=7.11; 95%CI=6.65–7.59) had a strong family history of colorectal cancer; (ii) 
13% of families (SIR=2.94; 95%CI=2.78–3.10) had a moderate family history of colorectal 
cancer; (iii) 11% of families (SIR=1.23; 95%CI=1.12–1.36) had a strong family history of breast 
cancer and weak family history of colorectal cancer; (iv) 9% of families (SIR=1.06; 95% 
CI=0.96–1.18) had a strong family history of prostate cancer and a weak family history of 
colorectal cancer; and (v) 60% of families (SIR=0.61; 95%CI=0.57–0.65) had weak family history 
of all cancers. There is a wide variation of colorectal cancer risk that can be categorized by family 
history of cancer, with a strong gradient of colorectal cancer risk between the highest and lowest 
risk categories. The risk of colorectal cancer for people with the highest risk category of family 
history (7% of the population) was 12-times that for people in the lowest risk category (60%) of 
the population. Data mining was proven an effective approach for gaining insight into the 
underlying cancer aggregation patterns and for categorizing familial risk of colorectal cancer.
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INTRODUCTION
The risk of colorectal cancer is strongly associated with family history of colorectal cancer. 
First-degree relatives of colorectal cancer cases have, on average, an approximate two-fold 
risk of the disease compared with those without a family history [1, 2]. Knowledge of this 
risk factor, has led to the development of guidelines for colorectal cancer screening based on 
family history and research to identify the genetic factors that contribute to this familial risk. 
Hereditary cancer syndromes, such as Lynch syndrome and familial adenomatous polyposis, 
for which underlying genetic mutations have been identified, are major achievements, yet 
account for the minority of this familial aggregation [3]. A more comprehensive assessment 
of how familial aggregation of cancer affects colorectal cancer risk, and the distribution of 
this risk, would provide the basis for formulating new genetic and genomic research, and 
development of improved clinical management of colorectal cancer families, including 
refining targeted genetic and cancer screening recommendations. The distribution of familial 
risk was first analyzed by Fain and Goldgar using a non-parametric test applying to breast 
cancer family history data [4].
Most studies investigating associations between family history and risk of colorectal cancer 
have limited their analysis of family history to first-degree relatives only [5–10] with only a 
few that included up to third-degree relatives [1, 11]. Most have not considered family 
history of cancers other than colorectal and have used simple counts of cancers without 
considering the size of the family or degree of relationship. A limitation of this approach is 
that the underlying association between the constellation of affected relatives and the 
patterns of aggregation of cancer in relatives is not taken into account. A more 
comprehensive approach is to address the question:
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“What is a person’s risk of colorectal cancer if l of this person’s x first-degree 
relatives had cancer a, b, c …, and m of this person’s y second-degree relatives had 
cancer a, b, c, …, and n of this persons’s z third-degree relatives had cancer a, b, c, 
…?”
To the best of our knowledge, no study has reported the distribution of risk of colorectal 
cancer, taking into consideration both the underlying association between the patterns of 
affected relatives (constellations) and the spectrum of co-aggregating cancers 
(aggregations). We have attempted to fill this gap by conducting a novel data mining 




We studied population-based colorectal cancer families recruited to the Colon Cancer 
Family Registry [12]. Detail description of recruitment can be found at http://coloncfr.org/. 
For this analysis, we studied the families that were recruited through recently diagnosed 
invasive colorectal cancer cases (population-based probands) from state or regional 
population cancer registries in the USA (Washington, California, Arizona, Minnesota, 
Colorado, New Hampshire, North Carolina, and Hawaii), Australia (Victoria) and Canada 
(Ontario) between 1997 and 2007. Population-based probands were recruited regardless of 
having a family history of cancer. Written informed consent was obtained from all study 
participants, and the study protocol was approved by the institutional research ethics review 
board at each study center.
Data Collection
Information on demographics, personal characteristics, personal and family history of 
cancer, cancer-screening history, and history of polyps, polypectomy, and other surgeries 
was obtained by questionnaires from all probands and participating relatives. Cancer 
histories were also cross checked across multiple relatives from within the same family, not 
just the probands. Participants were followed up approximately every five years after 
baseline to update this information. The present study was based on all available baseline 
and follow-up data. Reported cancer diagnoses and age at diagnosis were confirmed, where 
possible, using pathology reports, medical records, cancer registry reports, and death 
certificates. Blood samples and permission to access tumor tissue were requested from all 
participants.
Mismatch repair (MMR) gene mutation testing
Testing for germline mutations in MLH1, MSH2, MSH6 and PMS2 was performed for all 
population-based probands who had a colorectal cancer displaying MMR deficiency as 
evidenced by either tumor microsatellite instability and/or lack of MMR protein expression 
by immunohistochemistry. Details of germline testing methods have been described 
elsewhere [13]. A pathogenic mutation was defined as a variant that was predicted to result 
in a stop codon, a frameshift mutation, a large duplication or deletion, or a missense 
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mutation in the coding region or splice site previously reported within the scientific 
literature and databases to be pathogenic (InSiGHT database; http://insight-group.org/
variants/classifications/). The relatives of probands with a pathogenic MMR germline 
mutation, who provided a blood sample, underwent testing for the specific mutation 
identified in the proband.
Definitions
Self-organizing map [14] is a method for projecting high-dimensional data onto low-
dimensional output display. A node corresponds to a group of families with similar familial 
aggregation vectors and is determined using a self-organizing map. K-means [15] is a 
technique for partitioning data into optimal groups. A cluster is a grouping of nodes on the 
self-organizing map detected by k-means. A codebook vector refers to the weight vector of 
each node for the self-organizing map. A prototype vector is used to describe the mean 
weight vector for a cluster computed by k-means.
Statistical Analysis
Data mining framework—To analyze family history, we used data mining [16] to reveal 
patterns of familial aggregation that can be used to estimate the colorectal cancer risk of an 
individual based on their family history of cancers. Every family was represented by a 
vector modeling family history of cancer. These vectors became the inputs to the clustering 
algorithms, including the self-organizing map [14] and k-means [15], to identify nodes and 
clusters. Finally, the risk of colorectal cancer was estimated for each detected nodes and 
cluster (see Supplementary Figure 1).
(1) Familial aggregation: Family history of each cancer type was transformed into a 
familial aggregation index that encapsulated the aggregation in each family with the key 
property that family history of cancer for a person is stronger the larger numbers of relatives 
with cancer and the closer the genetic relationship they have to these affected relatives. To 
this end, the vector of familial aggregation of all cancers for each family based on the 
familial relationship to the proband, was calculated as follows:
where F_Aggci is a familial aggregation index defined as:
with
#FDR, #SDR, #TDR as the numbers of first-, second- and third-degree relatives the 
proband has, and
#FDRci, #SDRci, #TDRci as the numbers of first-, second- and third-degree relatives of 
the proband being affected by cancer ci.
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(2) Cluster detection: First, the self-organizing map [14] (a non-parametric clustering 
algorithm from the artificial neural network [17] discipline) was applied to group families 
with similar family history as defined by their familial aggregation index into nodes so that 
neighboring nodes are more similar than distant ones. Second, k-means [15] was used to 
identify global characteristics of familial aggregation by partitioning the nodes into larger 
clusters so that similarity within cluster and difference between clusters were maximized.
A 6×12 (72 nodes) self-organizing map was used. The number of nodes was initially set to 
, where n was the number of families, and the vertical and horizontal dimension was 
defined by the ratio of the two largest eigenvalues of the dataset. The final map size used 
was chosen by scaling up or down the reference map to achieve maximum map resolution 
within computational constraints [18].
To find a global perspective for the familial aggregation, families grouped by nodes on the 
self-organizing map were further clustered using k-means, where k is the number of clusters 
to be found. K-means is a partitioning clustering algorithm useful for providing groupings 
with explicit cluster boundaries [15]. All cluster detection tasks were done using the 
scientific programming package Matlab R2012a [19]. Technical details of the cluster 
detection step, including (1) clustering families using the self-organizing map, (2) 
partitioning self-organizing map using k-means, and (3) distance measure for measuring 
similarity of familial aggregation, are described in the Appendix A, B and C, respectively.
(3) Epidemiologic analysis: To determine the degree of colorectal cancer risk for family 
members of each node and cluster compared with the general population, we estimated the 
standardized incidence ratio (SIR) by dividing the numbers of colorectal cancers observed in 
all family members (excluding the proband) of each node and cluster by the expected 
numbers [20]. The expected numbers of colorectal cancers for each node and cluster were 
calculated by multiplying the age-, sex-, and country-specific incidence for the general 
population by the corresponding observation time (i.e. age) of the family members. Age- 
and sex-specific cancer incidences for each country in 1988–1992 were obtained from the 
Cancer Incidence in Five Continents [21]. The corresponding 95% confidence intervals 
(CIs) were calculated by taking into account familial correlation of cancer risk between 
relatives using the Jackknife method [22].
To deal with missing age(s) at diagnosis of cancer for affected relatives, we assumed the 
median age at diagnosis for each cancer in the general population obtained from 
Surveillance, Epidemiology and End Results Cancer Statistics Review [23]. Unaffected 
relatives for whom no information on age was available were censored at birth and therefore 
did not contribute to the analysis. All epidemiologic analysis was done using Stata 11.0 [24].
We conducted a sensitivity analysis to assess the role of an inherited cancer risk syndrome 
on familial clustering and SIR estimation by excluding the 201 families known to be 
carrying a DNA mismatch repair gene mutation (Lynch syndrome families). We conducted a 
sensitivity analysis to assess the role of family history of third-degree relatives by restricting 
analysis to only first- and second-degree relatives.
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Of the 10,407 families identified from population-based resources of the Colon Cancer 
Family Registry, 341 families (3%) were excluded because of having less than four family 
members. The remaining 10,066 families that contained 181,555 individuals (90,188 
women) were included. On average, each family had 7 first-degree relatives, 9 second-
degree relatives and 5 third-degree relatives (Table 1). We identified sixty-six minor clusters 
of familial risk for developing colorectal cancer (Figure 1). There were 5 major clusters 
corresponding to an optimal partition capturing the most representative family history 
patterns associated with various degrees of risk for developing colorectal cancer 
(Supplementary Figure 2). Demographic characteristics of each cluster are summarized in 
Table 2.
Identification of the familial risk
There was a moderate variation in colorectal cancer risk across nodes within each cluster 
(Figure 1) and a wide variation in colorectal cancer risk across clusters in terms of both the 
type and strength of aggregation of extracolonic cancers and the strength of aggregation of 
colorectal cancer (Figure 2).
Familial risk for each cluster
Members of families with the strongest aggregation of colorectal cancer had the highest risk 
of the disease (Cluster 5 in Figure 2), with an average seven-fold increased risk of colorectal 
cancer compared with the general population (SIR = 7.11; 95% CI = 6.65 to 7.59). Within 
this cluster, the increased risk of colorectal cancer ranged from 1.64 to 4.22 (between the 13 
nodes). This cluster comprised 1,353 families, which was 13% of all families, and the 
median age of disease onset was 69 (inter-quartile range 52–72) years. Members of families 
with the second highest aggregation of colorectal cancer (Cluster 4 in Figure 2), had an 
average three-fold increased risk of colorectal cancer (SIR = 2.94; 95% CI = 2.78 to 3.10). 
Within this cluster, the increased risk of colorectal cancer ranged from 1.64 to 4.22 (between 
the 13 nodes). This cluster comprised 1,353 families, which was 13% of all families, and the 
median age of disease onset is 69 (inter-quartile range 52–72) years. In contrast, colorectal 
cancer risk was the lowest for members of families with weak aggregation of colorectal 
cancer (Cluster 1 in Figure 2). They had an average risk of colorectal cancer 40% lower than 
the general population (SIR = 0.61; 95% CI = 0.57 to 0.65). Within this cluster, the 
increased risk of colorectal cancer ranged from 0.1 to 2.34 (between the 24 nodes). This 
cluster comprised 5,969 families, which was 60% of all families, and the median age of 
disease onset was 70 (inter-quartile range 56–72) years.
Members of families with a strong aggregation of breast cancer and weak aggregation of 
colorectal cancer (Cluster 3 in Figure 2) had a modest increased risk of colorectal cancer 
(SIR = 1.23; 95% CI = 1.12 to 1.36) i.e., familial aggregation of breast cancer was a risk 
factor for colorectal cancer. Within this cluster, the increased risk of colorectal cancer 
ranged from 0.24 to 3.89 (between the 10 nodes). This cluster comprised 1,087 families, 
which was 11% of all families, and the median age of disease onset was 71 (inter-quartile 
range 61–72) years. Members of families with a strong aggregation of prostate cancer and 
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weak aggregation of colorectal cancer (Cluster 2 in Figure 2) had no increased risk of 
colorectal cancer (SIR = 1.06; 95% CI = 0.96 to 1.18) i.e., familial aggregation of prostate 
cancer was not a risk factor for colorectal cancer. Within this cluster, the increased risk of 
colorectal cancer ranged from 0.27 to 2.93 (between the 11 nodes). This cluster comprised 
915 families, which was 9% of all families, and the median age of disease onset was 71 
(inter-quartile range 43–74) years.
Extracolonic cancers co-aggregated with colorectal cancer in all five clusters but the 
aggregations were all weak and no particular cancer appeared to be a risk factor for 
colorectal cancer except in Cluster 3. Averaged across all nodes in all clusters weighted by 
the number of families in each node, the SIR was 1.59 (95% CI = 1.54 to 1.65).
Distribution of familial risks by clusters
Figure 3A shows the distribution of SIRs of colorectal cancer for all family members within 
each node for each of the five clusters. Familial risk distributions were similarly right 
skewed for Clusters 1, 2 and 3): about 90% of families in Cluster 1 had a lower risk of 
colorectal cancer than the general population; about 80% in Cluster 2; and about 60% in 
Cluster 3. When we compared the familial risks (expressed as SIRs) between different 
clusters, there was a strong gradient between them (Figure 3B). The ratio of the SIRs 
between the highest risk category of family history (Cluster 5) and the lowest risk category 
(Cluster 1), was 11.67. When combined across all nodes in all clusters, i.e. all families, the 
overall distribution of familial risks in the whole study sample was right skewed with a long 
tail (Figure 4).
Sensitivity analyses
There were 201 (2%) families in which at least one family member was identified as having 
a MMR gene mutation (Lynch syndrome). Excluding the Lynch syndrome families made no 
substantial difference to the findings in terms of self-organizing map patterns, distributions 
of aggregating cancers in families, age at diagnosis, or SIR of colorectal cancer in any 
cluster (Supplementary Figure 3). The distribution of familial clusters for Lynch syndrome 
families, median age at diagnosis and SIR of colorectal cancer for each cluster are shown in 
Supplementary Table 1. Similarly, excluding all third-degree relatives made no substantial 
difference (detail data not shown).
DISCUSSION
In this study, we identified patterns of familial aggregation and simultaneously assessed risk 
of colorectal cancer for these familial aggregation patterns, instead of estimating risk only 
based on numbers of affected relatives and degree of relatedness as in previous studies [25–
28]. We used a novel data mining approach, which facilitated the clustering of both 
constellation patterns and familial cancer aggregation. The multivariable nature of this 
approach is particularly relevant for examining risk where cancers at multiple organ sites 
can co-aggregate within the family.
We found that the overall distribution of the familial risks of colorectal cancer across the 
whole study sample (all of whom had at least one relative with colorectal cancer, i.e. the 
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proband) to be right skewed (Figure 4). This is consistent with the description of familial 
risks of people in the general population by Hopper [29] (see Figure 2 in [29]): under the 
assumption of a multiplicative polygenic risk model, the distribution of familial risks for 
colorectal cancer for the general population (and in our case, families with at least one 
colorectal cancer) is skewed with a long tail, and the mode of the familial risk is 
substantially below the population average of 5% risk. Moreover, a trend parallel to 
Hopper’s description was clearly observed in our cluster familial risk distributions. The 
average familial risk distributions spread further to the right as more close relatives are 
affected [29, 30]. Starting from the lowest risk category (Cluster 1), as the average familial 
risk increases (Cluster 2 and 3), the distribution of the familial risks moves to the right 
(Cluster 4 and 5). We, therefore, provide empirical evidence for the existence of a wide 
variation of familial risks (even within a set of families ascertained because of a colorectal 
cancer case), and a strong gradient of colorectal cancer risk between the highest and lowest 
risk groups for colorectal cancer. We also found that the types and aggregation of 
extracolonic cancers and strength of the aggregation of colorectal cancer in a family might 
explain this wide variation of familial risks of colorectal cancer.
This study has some limitations. The clustering results of the self-organizing map might not 
be identical every time it is run though they were very similar consistently. This is a 
common issue for neural network models and optimization problems in general. However, it 
is not a major concern here because the focus is in identifying a small finite set of 
representative prototypes (i.e. the familial risk categories) by minimizing the quantization 
error of the neural network model. These prototypes are formed as averages of the data 
within a cluster. Variations of these averages are insignificant when the number of training 
data is sufficiently large, as in our case.
The contribution this study could make to the field is two-fold. First, the findings about the 
familial risk distribution will serve as empirical evidence supporting existing familial risk 
models confirming that, for colorectal cancer, there exist a wide variation of familial risks, 
and a very strong risk gradient between the highest and lowest risk groups [29, 31]. Second, 
the data mining approach will advance current familial studies which are limited to 
univariable analysis to addressing the multivariable question, relevant to the studies of other 
familial cancer syndromes.
In conclusion, our data mining approach showed a wide variation of familial colorectal 
cancer risk and a strong risk gradient between the highest risk and lowest risk families. The 
types and aggregation of extracolonic cancers and strength of the aggregation of colorectal 
cancer in a family might explain this wide variation of familial risks. A family history of 
colorectal cancer with a broad spectrum of co-aggregating cancers could substantially 
elevate the risk of colorectal cancer; but co-aggregating extracolonic cancers may not 
influence the risk of colorectal cancer when the familial aggregation of colorectal cancer is 
not strong. Data mining was proven an effective approach for gaining insight to the 
underlying cancer aggregation patterns and for categorizing familial risk of colorectal 
cancer.
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Familial risks for population-based colorectal cancer families from the Colon Cancer Family 
Registry. The number in the right top corner represents the standardized incidence ratio of 
colorectal cancer. Node without a bar chart in the diagram is an empty node with no families 
mapped to it. crc = colorectal cancer, ec = endometrial cancer, stom = stomach cancer, smlb 
= small bowel cancer, hb = hepatobiliary cancer, pan = pancreatic cancer, ren = renal cancer, 
uret = ureteric cancer, blad = urinary bladder cancer, brain = brain cancer, cerv = cervical 
cancer, ovar = ovarian cancer, brst = breast cancer, prost = prostate cancer
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Familial risk of colorectal cancer by each cluster. SIR = standardized incidence ratio of 
colorectal cancer (corresponding 95% confidence interval), ageDX = age at diagnosis of 
colorectal cancer (years), crc = colorectal cancer, ec = endometrial cancer, stom = stomach 
cancer, smlb = small bowel cancer, hb = hepatobiliary cancer, pan = pancreatic cancer, ren = 
renal cancer, uret = ureteric cancer, blad = urinary bladder cancer, brain = brain cancer, cerv 
= cervical cancer, ovar = ovarian cancer, brst = breast cancer, prost = prostate cancer
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(A) Distribution of familial risk of colorectal cancer by family clusters (expressed as the 
standardized incidence ratios (SIRs)). The normalized frequency, corresponding to the 
height of each bar, indicates the percentage of families with the same colorectal cancer risk. 
(B) SIRs and their 95% confidence intervals (CIs) for each family cluster. The dot points 
represent the estimates of SIR and the vertical lines represent 95% CIs.
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Mapping between familial risk distribution and cancer aggregation patterns. SIR = 
standardized incidence ratio of colorectal cancer, ageDX = age at diagnosis of colorectal 
cancer (years), crc = colorectal cancer, ec = endometrial cancer, stom = stomach cancer, 
smlb = small bowel cancer, hb = hepatobiliary cancer, pan = pancreatic cancer, ren = renal 
cancer, uret = ureteric cancer, blad = urinary bladder cancer, brain = brain cancer, cerv = 
cervical cancer, ovar = ovarian cancer, brst = breast cancer, prost = prostate cancer
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Table 1
Baseline characteristics of population-based families from the Colon Cancer Family Registry
Characteristics Number
No. of families 10,066
No. of persons 181,555
  Canada 60,875 (34%)
  Australia 34,669 (19%)
  USA 86,011 (47%)
Male : Female 1 : 1.01
Age (median) 57
Cancers
  Colorectal cancer 6,808
  Endometrial cancer 858
  Stomach cancer 1,526
  Small bowel cancer 46
  Hepatobiliary tract cancer 754
  Pancreatic cancer 680
  Renal cancer 478
  Ureter cancer 32
  Bladder cancer 504
  Brain cancer 806
  Cervical cancer 586
  Ovarian cancer 610
  Breast cancer 3,841
  Prostate cancer 2,470
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Table 2
Demographic characteristics of the five clusters
Cluster No of families No of persons Male : Female Age (years)
median (inter-quartile range)
1 5,969 (59%) 96,326 1 : 1.02 56 (40–72)
2 915 (9%) 19,544 1 : 1.02 59 (43–74)
3 1,087 (11%) 19,916 1 : 0.95 59 (43–73)
4 1,353 (13%) 33,938 1 : 1.01 57 (40–73)
5 742 (7%) 11,831 1 : 0.99 58 (42–72)
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